LSMD was nominally statistically significant ( P < @ ) for levomilnacipran ER versus placebo in @ domains ( General Health -LSB- @ ; P = @ -RSB- , Vitality -LSB- @ ; P = @ -RSB- , Social Functioning -LSB- @ ; P = @ -RSB- , Role-Emotional -LSB- @ ; P = @ -RSB- , Mental Health -LSB- @ ; P = @ -RSB- ) ; changes in Vitality , Social Functioning , and Mental Health exceeded MID .